Latest news and blogs
GlaxoSmithKline (GSK) has told us it is having problems with the supply of Lamictal. This is due to manufacturing problems.
A mother and son who both have epilepsy have started a petition to persuade the UK government to re-invest a recent pharmaceutical company fine into epilepsy healthcare services.
Pfizer and Flynn Pharma were fined £84.2m and £5.2m respectively for over-charging the NHS for life-saving epilepsy medicine phenytoin sodium.